
|Articles|October 23, 2014
US Healthcare Reform: A Pharm Exec Digest Special
Author(s)The Pharm Exec staff
This month’s special issue of Pharm Exec Global Digest looks at..
Advertisement
This month’s special issue of Pharm Exec Global Digest looks at
- Dealing with the “side effects” of Obamacare
- The “value” of Rxs under Obamacare
- The escalating cost of US oncology care
- And more…
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS
2
Uncertainty Surrounding Pharma Tariff Deadlines
3
Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge
4
Targeted Onshoring's Impact on Domestic Pharma Manufacturing
5




